Skip to main content

Table 3 Multivariate analyses between different variables and LS BMD change at 12 months

From: Analyzing the factors associated with efficacy among teriparatide treatment in postmenopausal women with osteoporosis

Risk factors

Absolute change

 

Estimate (r)

95%CI

P value

Gastrointestinal disease

-0.1721034

-0.2931635538 - (-0.051043176)

0.005518**

Bisphosphonates

-0.1795748

-0.3387616315 - (-0.020387906)

0.027203*

Glucocorticoid

-0.1449302

-0.2604801397 - (-0.029380199)

0.014178*

Menatetrenone

0.1427399

0.0460707088–0.239409133

0.003970**

25(OH)D level at baseline

0.0122580

0.0074742986–0.017041711

8.84e-07***

PINP level at baseline

0.0005970

-0.0009609306–0.002154868

0.451084

PINP increment (3 month)

0.0024547

0.0016720266–0.003237379

2.76e-09***

β-CTX increment (3 month)

-0.0484735

-0.1877221096–0.090775017

0.493541

Smoking

-0.0616644

-0.195963231–0.0726345088

0.366641

Tea

-0.0525861

-0.208323190–0.1031510294

0.506591

Coffee

-0.1030199

-0.261151875–0.0551119760

0.200607

Alcohol

-0.0639997

-0.206269747–0.0782702642

0.376422

Western Dieta

0.0573259

-0.0414822115–0.156134037

0.254226

Asian Dieta

-0.0444775

-0.1294011073–0.040446011

0.303248

Vegetarian Dieta

-0.2043182

-0.3265763246 - (-0.082060024)

0.001144**

ALT

0.0023003

-0.0007605353–0.005361098

0.140071

BMD at baseline

-0.1151999

-0.1534059432 - (-0.076993822)

9.96e-09***

  1. aEstimate was compared with Mediterranean Diet